Vicore Pharma Holding AB
No trades
No trades
Peers for comparison
−2.04 USD
−48.68 M USD
389.19 K USD
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Ahmed S. Mousa
Website
Headquarters
Stockholm
Founded
2000
ISIN
US92581R1041
CUSIP
92581R104
FIGI
BBG023F21HG4
Identifiers
ISIN US92581R1041
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral